News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Kenneth M. Verburg, for the SUCCESS VI Study Group (Reprinted from Th

Articles by Kenneth M. Verburg, for the SUCCESS VI Study Group (Reprinted from Th

Cyclooxygenase-2-Specific Inhibitors and Cardiorenal Function: A Randomized, Controlled Trial of Celecoxib and Rofecoxib in Older Hypertensive Osteoarthritis Patients

ByAndrew Whelton,John G. Fort,Joseph A. Puma,Diane Normandin,Alfonso E. Bello,Kenneth M. Verburg, for the SUCCESS VI Study Group (Reprinted from Th

October 1st 2002

Latest Updated Articles

Cyclooxygenase-2-Specific Inhibitors and Cardiorenal Function: A Randomized, Controlled Trial of Celecoxib and Rofecoxib in Older Hypertensive Osteoarthritis Patients
October 1st 2002

Trending on AJMC

5 Things to Know About the FDA's Peptide Reversal

US Employer Health Care Costs Projected to Rise 9.5% in 2027

Student Mental Health, Success Tied to Future Health and Affordability

FDA Approves First Orexin Agonist for Narcolepsy Type 1

Mobile Integrated Health Valuable in Heart Failure, but Payment Lags